Return on Equity (ROE)
since 2005
Calculation
Johnson & Johnson, ROE, long-term trends, calculation
| ROE | = | 100 | × | Net earnings1 | ÷ | Shareholders’ equity1 | |
|---|---|---|---|---|---|---|---|
| Dec 29, 2024 | 19.68% | = | 100 | × | 14,066) | ÷ | 71,490) |
| Dec 31, 2023 | 51.11% | = | 100 | × | 35,153) | ÷ | 68,774) |
| Dec 31, 2022 | 23.36% | = | 100 | × | 17,941) | ÷ | 76,804) |
| Dec 31, 2021 | 28.20% | = | 100 | × | 20,878) | ÷ | 74,023) |
| Dec 31, 2020 | 23.25% | = | 100 | × | 14,714) | ÷ | 63,278) |
| Dec 29, 2019 | 25.42% | = | 100 | × | 15,119) | ÷ | 59,471) |
| Dec 30, 2018 | 25.60% | = | 100 | × | 15,297) | ÷ | 59,752) |
| Dec 31, 2017 | 2.16% | = | 100 | × | 1,300) | ÷ | 60,160) |
| Dec 31, 2016 | 23.49% | = | 100 | × | 16,540) | ÷ | 70,418) |
| Dec 31, 2015 | 21.66% | = | 100 | × | 15,409) | ÷ | 71,150) |
| Dec 28, 2014 | 23.40% | = | 100 | × | 16,323) | ÷ | 69,752) |
| Dec 29, 2013 | 18.68% | = | 100 | × | 13,831) | ÷ | 74,053) |
| Dec 30, 2012 | 16.74% | = | 100 | × | 10,853) | ÷ | 64,826) |
| Dec 31, 2011 | 16.94% | = | 100 | × | 9,672) | ÷ | 57,080) |
| Dec 31, 2010 | 23.57% | = | 100 | × | 13,334) | ÷ | 56,579) |
| Dec 31, 2009 | 24.25% | = | 100 | × | 12,266) | ÷ | 50,588) |
| Dec 28, 2008 | 30.46% | = | 100 | × | 12,949) | ÷ | 42,511) |
| Dec 30, 2007 | 24.41% | = | 100 | × | 10,576) | ÷ | 43,319) |
| Dec 31, 2006 | 28.11% | = | 100 | × | 11,053) | ÷ | 39,318) |
| Dec 31, 2005 | 27.49% | = | 100 | × | 10,411) | ÷ | 37,871) |
Based on: 10-K (reporting date: 2024-12-29), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in millions
Comparison to Competitors
Johnson & Johnson, ROE, long-term trends, comparison to competitors
| Johnson & Johnson | AbbVie Inc. | Amgen Inc. | Bristol-Myers Squibb Co. | Danaher Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Merck & Co. Inc. | Pfizer Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 29, 2024 | 19.68% | 128.66% | 69.59% | — | 7.87% | 74.62% | — | — | — | 15.03% | 12.78% | — |
| Dec 31, 2023 | 51.11% | 46.94% | 107.78% | 27.27% | 8.91% | 48.65% | 24.81% | 0.97% | 2.38% | 15.22% | 12.83% | 20.59% |
| Dec 31, 2022 | 23.36% | 68.60% | 178.97% | 20.37% | 14.39% | 58.64% | 21.62% | 31.57% | 32.79% | 19.14% | 15.80% | 23.88% |
| Dec 31, 2021 | 28.20% | 74.91% | 87.96% | 19.46% | 14.24% | 62.16% | 29.55% | 34.17% | 28.47% | 43.03% | 18.94% | 23.19% |
| Dec 31, 2020 | 23.25% | 35.30% | 77.20% | -23.84% | 9.17% | 109.79% | 0.68% | 27.91% | 15.21% | 31.86% | 18.47% | 31.22% |
| Dec 29, 2019 | 25.42% | — | 81.07% | 6.66% | 9.94% | 319.09% | 23.91% | 37.99% | 25.77% | 19.08% | 12.45% | 19.34% |
| Dec 30, 2018 | 25.60% | — | 67.15% | 35.07% | 9.40% | 32.88% | 25.51% | 23.30% | 17.59% | 27.91% | 10.65% | 47.28% |
| Dec 31, 2017 | 2.16% | 104.16% | 7.84% | 8.58% | 9.45% | -1.76% | 22.64% | 6.97% | 29.47% | 19.51% | 8.76% | 12.99% |
| Dec 31, 2016 | 23.49% | 128.41% | 25.85% | 27.55% | 11.10% | 19.54% | 71.48% | 9.78% | 12.12% | 20.13% | 9.39% | -9.69% |
| Dec 31, 2015 | 21.66% | 130.39% | 24.71% | 10.97% | 14.17% | 16.53% | 97.70% | 9.94% | 10.75% | 17.40% | 9.25% | -59.19% |
| Dec 28, 2014 | 23.40% | 101.84% | 20.01% | 13.49% | 11.11% | 15.55% | 78.45% | 24.50% | 12.81% | 13.69% | 9.22% | -68.70% |
| Dec 29, 2013 | 18.68% | 91.90% | 23.00% | 16.91% | 12.04% | 26.57% | 27.05% | 8.85% | 28.83% | 21.74% | 7.55% | -32.81% |
| Dec 30, 2012 | 16.74% | 156.85% | 22.80% | 14.39% | 12.58% | 27.69% | 27.84% | 11.63% | 17.93% | 60.24% | 7.62% | -10.71% |
| Dec 31, 2011 | 16.94% | — | 19.35% | 23.25% | 12.85% | 32.11% | 41.60% | 11.50% | 12.18% | -45.65% | 8.84% | 3.76% |
| Dec 31, 2010 | 23.57% | — | 19.32% | 19.74% | 13.08% | 40.82% | 49.48% | 1.58% | 9.40% | -19.79% | 6.74% | -149.74% |
| Dec 31, 2009 | 24.25% | — | 20.32% | 71.49% | 9.90% | 45.45% | 41.40% | 21.85% | 9.59% | -17.10% | 5.51% | -58.57% |
| Dec 28, 2008 | 30.46% | — | 20.58% | 42.86% | 13.43% | -30.76% | 48.43% | 41.63% | 14.08% | -19.75% | 6.66% | -192.51% |
| Dec 30, 2007 | 24.41% | — | 17.72% | 20.50% | 15.08% | 21.61% | 46.69% | 18.01% | 12.53% | -22.94% | 5.25% | -144.23% |
| Dec 31, 2006 | 28.11% | — | 15.56% | 15.86% | 16.89% | 24.25% | -65.54% | 25.25% | 27.10% | -47.24% | 1.21% | -40.89% |
| Dec 31, 2005 | 27.49% | — | 17.96% | 26.77% | 17.67% | 18.34% | 26.88% | 25.85% | 12.32% | -83.72% | 7.99% | -85.05% |
Based on: 10-K (reporting date: 2024-12-29), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Pharmaceuticals, Biotechnology & Life Sciences)
Johnson & Johnson, ROE, long-term trends, comparison to sector (pharmaceuticals, biotechnology & life sciences)
| Johnson & Johnson | Pharmaceuticals, Biotechnology & Life Sciences | |
|---|---|---|
| Dec 29, 2024 | 19.68% | — |
| Dec 31, 2023 | 51.11% | 20.65% |
| Dec 31, 2022 | 23.36% | 27.99% |
| Dec 31, 2021 | 28.20% | 29.75% |
| Dec 31, 2020 | 23.25% | 17.22% |
| Dec 29, 2019 | 25.42% | 27.68% |
| Dec 30, 2018 | 25.60% | 26.29% |
| Dec 31, 2017 | 2.16% | 14.59% |
| Dec 31, 2016 | 23.49% | 22.19% |
| Dec 31, 2015 | 21.66% | 21.44% |
| Dec 28, 2014 | 23.40% | 20.91% |
| Dec 29, 2013 | 18.68% | 20.33% |
| Dec 30, 2012 | 16.74% | 18.27% |
| Dec 31, 2011 | 16.94% | 15.52% |
| Dec 31, 2010 | 23.57% | 13.99% |
| Dec 31, 2009 | 24.25% | 20.34% |
| Dec 28, 2008 | 30.46% | 21.31% |
| Dec 30, 2007 | 24.41% | 17.07% |
| Dec 31, 2006 | 28.11% | 21.86% |
| Dec 31, 2005 | 27.49% | 19.08% |
Based on: 10-K (reporting date: 2024-12-29), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Johnson & Johnson, ROE, long-term trends, comparison to industry (health care)
| Johnson & Johnson | Health Care | |
|---|---|---|
| Dec 29, 2024 | 19.68% | — |
| Dec 31, 2023 | 51.11% | 18.07% |
| Dec 31, 2022 | 23.36% | 22.47% |
| Dec 31, 2021 | 28.20% | 22.98% |
| Dec 31, 2020 | 23.25% | 16.02% |
| Dec 29, 2019 | 25.42% | 20.98% |
| Dec 30, 2018 | 25.60% | 17.71% |
| Dec 31, 2017 | 2.16% | 14.11% |
| Dec 31, 2016 | 23.49% | 18.09% |
| Dec 31, 2015 | 21.66% | 18.16% |
| Dec 28, 2014 | 23.40% | 18.60% |
| Dec 29, 2013 | 18.68% | 18.15% |
| Dec 30, 2012 | 16.74% | 17.49% |
| Dec 31, 2011 | 16.94% | 15.29% |
| Dec 31, 2010 | 23.57% | 14.41% |
| Dec 31, 2009 | 24.25% | 19.34% |
| Dec 28, 2008 | 30.46% | 18.87% |
| Dec 30, 2007 | 24.41% | 16.99% |
| Dec 31, 2006 | 28.11% | 20.34% |
| Dec 31, 2005 | 27.49% | 18.42% |
Based on: 10-K (reporting date: 2024-12-29), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-29), 10-K (reporting date: 2018-12-30), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-28), 10-K (reporting date: 2013-12-29), 10-K (reporting date: 2012-12-30), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-28), 10-K (reporting date: 2007-12-30), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).